Self-Medication Relieves German Funds

7 April 1996

The German drug industry association, the BPI, says that growing self-medication relieved the public-sector health funds of some 1 billion Deutschemarks ($676.5 million) of drug spending in 1995. German consumers purchased non-prescription drugs worth 8.5 billion marks ($5.75 billion) in all last year, up 10% on 1994.

Volume sales of self-medication products rose 6% to 7.2 billion marks in western Germany and 18% to 1.3 billion in the five eastern states. Self-medication accounted for 52% of a total non-prescription drug market of 16.4 billion marks.

The BPI notes that self-medication drug consumers have accounted for 17%-18% of total pharmacy sales for some years. The 88 companies in the BPI's self-medication division report that this proportion can be increased, but this will require the exemption of further drugs from the prescription-only category.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight